Literature DB >> 30865483

Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.

Xiaoming Jia1, Julia M Akeroyd2, Khurram Nasir3, Vijay Nambi1,4,5, Christie M Ballantyne1,5, Laura A Petersen2, Salim S Virani1,2,4,5.   

Abstract

Entities:  

Keywords:  icosapent ethyl

Mesh：

Substances：

Year:  2019        PMID： 30865483     DOI： 10.1161/CIRCULATIONAHA.118.038691

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions.

Authors:  Anurag Mehta; Dhruv Mahtta; Martha Gulati; Laurence S Sperling; Roger S Blumenthal; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2020-01-11       Impact factor: 5.113

Review 2.  Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session.

Authors:  Mahmoud Al Rifai; Xiaoming Jia; Mouaz H Al-Mallah; Michael D Miedema; Seth S Martin; Salim S Virani
Journal:  Curr Atheroscler Rep       Date:  2019-05-24       Impact factor: 5.113

3.  Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 to 2016.

Authors:  Maxwell Birger; Alexander S Kaldjian; Gregory A Roth; Andrew E Moran; Joseph L Dieleman; Brandon K Bellows
Journal:  Circulation       Date:  2021-04-30       Impact factor: 39.918

Review 4.  Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date.

Authors:  Xiaoming Jia; Stephanie Koh; Mahmoud Al Rifai; Roger S Blumenthal; Salim S Virani
Journal:  Vasc Health Risk Manag       Date:  2020-01-09

5.  Applicability of the REDUCE-IT trial to the FAST-MI registry. Are the results of randomized trials relevant in routine clinical practice?

Authors:  Jean Ferrières; Vincent Bataille; Etienne Puymirat; François Schiele; Tabassome Simon; Nicolas Danchin
Journal:  Clin Cardiol       Date:  2020-07-28       Impact factor: 2.882

6.  Highlights From the American Heart Association's EPI|LIFESTYLE 2019 Scientific Sessions.

Authors:  Alvaro Alonso; Madison D Anderson; Michael P Bancks; Sherry-Ann Brown; Melissa C Caughey; Alex R Chang; Erin Delker; Kathryn Foti; Véronique Gingras; Michael G Nanna; Alexander C Razavi; Jewel Scott; Elizabeth Selvin; Catherine Tcheandjieu; Alvin G Thomas; Ruth-Alma N Turkson-Ocran; Allison Webel; Deborah R Young; Bailey M DeBarmore
Journal:  J Am Heart Assoc       Date:  2019-06-01       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.